BDNF Overexpression in the Ventral Hippocampus Promotes Antidepressant- and Anxiolytic-Like Activity in Serotonin Transporter Knockout Rats

• Published in: International journal of molecular sciences Vol. 22; no. 9; p. 5040
• Main Authors: Diniz, Danielle M., Calabrese, Francesca, Brivio, Paola, Riva, Marco A., Grandjean, Joanes, Homberg, Judith R.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 10.05.2021; MDPI
• Subjects: Animal models; Antidepressants; anxiety; Anxiolytics; BDNF; Behavior; Brain-derived neurotrophic factor; Corticosterone; depression; Emotional disorders; Gene expression; Hippocampus; Mental depression; Molecular modelling; Mood disorders; Neural plasticity; Neurogenesis; Phenotypes; Polymorphism; Proteins; Serotonin; serotonin knockout rats; Serotonin transporter; Signs and symptoms; Social behavior; Sucrose; Surgery
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22095040

BDNF plays a pivotal role in neuroplasticity events, vulnerability and resilience to stress-related disorders, being decreased in depressive patients and increased after antidepressant treatment. BDNF was found to be reduced in patients carrying the human polymorphism in the serotonin transporter promoter region (5-HTTLPR). The serotonin knockout rat (SERT−/−) is one of the animal models used to investigate the underlying molecular mechanisms of depression in humans. They present decreased BDNF levels, and anxiety- and depression-like behavior. To investigate whether upregulating BDNF would ameliorate the phenotype of SERT−/− rats, we overexpressed BDNF locally into the ventral hippocampus and submitted the animals to behavioral testing. The results showed that BDNF overexpression in the vHIP of SERT−/− rats promoted higher sucrose preference and sucrose intake; on the first day of the sucrose consumption test it decreased immobility time in the forced swim test and increased the time spent in the center of a novel environment. Furthermore, BDNF overexpression altered social behavior in SERT−/− rats, which presented increased passive contact with test partner and decreased solitary behavior. Finally, it promoted decrease in plasma corticosterone levels 60 min after restraint stress. In conclusion, modulation of BDNF IV levels in the vHIP of SERT−/− rats led to a positive behavioral outcome placing BDNF upregulation in the vHIP as a potential target to new therapeutic approaches to improve depressive symptoms.